1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Papillary Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Papillary Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Papillary Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Papillary Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Papillary Renal Cell Carcinoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Papillary Renal Cell Carcinoma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Papillary Renal Cell Carcinoma 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Papillary Renal Cell Carcinoma Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Novartis AG 25
Clinical Trial Overview of Novartis AG 25
GlaxoSmithKline plc 26
Clinical Trial Overview of GlaxoSmithKline plc 26
Eli Lilly and Company 27
Clinical Trial Overview of Eli Lilly and Company 27
Bristol-Myers Squibb Company 28
Clinical Trial Overview of Bristol-Myers Squibb Company 28
AstraZeneca PLC 29
Clinical Trial Overview of AstraZeneca PLC 29
Astellas Pharma Inc. 30
Clinical Trial Overview of Astellas Pharma Inc. 30
Clinical Trial Overview of Top Institutes / Government 31
National Cancer Institute 31
Clinical Trial Overview of National Cancer Institute 31
Fox Chase Cancer Center 32
Clinical Trial Overview of Fox Chase Cancer Center 32
Memorial Sloan Kettering Cancer Center 33
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 33
UNICANCER Group 34
Clinical Trial Overview of UNICANCER Group 34
Austrian Urogynecology Working Group 35
Clinical Trial Overview of Austrian Urogynecology Working Group 35
Ohio State University Comprehensive Cancer Center 36
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 36
Fred Hutchinson Cancer Research Center 37
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 37
Children's Oncology Group 38
Clinical Trial Overview of Children's Oncology Group 38
Five Key Clinical Profiles 39
Appendix 281
Abbreviations 281
Definitions 281
Research Methodology 282
Secondary Research 282
About GlobalData 283
Contact Us 283
Disclaimer 283
Source 284

List of Tables
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Papillary Renal Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Papillary Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Papillary Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Papillary Renal Cell Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014* 19
Papillary Renal Cell Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 19
Papillary Renal Cell Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014* 19
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Papillary Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 25
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 26
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 27
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 28
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 29
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 30
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 31
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2014* 32
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 33
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UNICANCER Group, 2014* 34
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Austrian Urogynecology Working Group, 2014* 35
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2014* 36
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 37
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 38

List of Figures
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Papillary Renal Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Papillary Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Papillary Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Papillary Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Papillary Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Papillary Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 282

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Renal Cancer: Analytical Tool

Renal Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Renal cell carcinoma- Market Insights, Epidemiology and Market Forecast-2023

Renal cell carcinoma- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Renal cell carcinoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...

Renal cell carcinoma - Epidemiology Forecast To 2023

Renal cell carcinoma - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Renal cell carcinoma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Renal cell carcinoma in seven major markets (US, France, Germany, Italy, Spain, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.